Source: Eur Respir J , 49 (3) 1601298; DOI: 10.1183/13993003.01298-2016
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Gunnar R. Husebø, Rune Grønseth, Lorena Lerner, Jeno Gyuris, Jon A. Hardie, Per S. Bakke, Tomas M. Eagan. Growth differentiation factor-15 is a predictor of important disease outcomes in patients with COPD. Eur Respir J , 49 (3) 1601298; DOI: 10.1183/13993003.01298-2016

Member's Comments

No comment yet.

Related content which might interest you: Growth differentiation factor-15 is a predictor for COPD exacerbations and survival Source: International Congress 2015 – COPD and lung function: risk factors and outcomes Year: 2015 Risk factor biomarker differences in rehospitalization for patients with COPD Source: Eur Respir J 2006; 28: Suppl. 50, 838s Year: 2006 Factors associated with poor prognostic outcome in acute exacerbation of COPD Source: Annual Congress 2009 - Treatment of airways disease Year: 2009 Markers of early disease and prognosis in COPD Source: Annual Congress 2009 - Epidemiology of COPD Year: 2009 Clinical characteristics and related risk factors of depression in patients with early COPD Source: International Congress 2018 – COPD and extrapulmonary comorbidities Year: 2018 Gender-dependent predictors for survival in patients with COPD Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases Year: 2019 The factors affecting the prognosis in COPD Source: Eur Respir J 2005; 26: Suppl. 49, 68s Year: 2005 The survival of patients afflicted with COPD and influencing factors Source: Annual Congress 2008 - Prognosis in COPD Year: 2008 CRP as predictor as predictor for late treatment failure in hospitalised patients with AECOPD Source: Annual Congress 2013 –COPD mechanisms Year: 2013 Risk factors of death in patients with COPD Source: Annual Congress 2009 - Prognosis and comorbidities in COPD Year: 2009 Exercise desaturation in patients with COPD – potent  marker for more severe disease progression and prognosis Source: International Congress 2017 – Exercise testing in cardiorespiratory diseases Year: 2017 Hypogonadism as a factor influencing health condition in COPD patients Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016 Plasma microfibrillar-associated protein 4 is not prognostic of emphysema progression but is associated with cardiovascular disease history and mortality in COPD patients Source: ERJ Open Res, 5 (2) 00021-2019; 10.1183/23120541.00021-2019 Year: 2019 Pilot: identification of rehospitalization risk factors for patients with COPD Source: Annual Congress 2005 - Assessment and intervention from primary care centre to hospital Year: 2005 Hypoxemia as a risk factor for endothelial dysfunction in COPD patients Source: Annual Congress 2013 –COPD diagnosis Year: 2013 Candidacolonization in lung cancer patients and its role as a prognostic factor for infection occurrence during hospitalization Source: Eur Respir J 2003; 22: Suppl. 45, 433s Year: 2003 Prognostic predictors of survival in patients with COPD hospitalized for an acute exacerbation Source: Eur Respir J 2005; 26: Suppl. 49, 284s Year: 2005 Risk factors for mortality in patients with COPD exacerbation Source: Annual Congress 2009 - Epidemiology of COPD Year: 2009 Predictive factors of mortality in COPD patients Source: Eur Respir J 2007; 30: Suppl. 51, 76s Year: 2007 Lung function reversibility as a predictor of disease progression in COPD Source: International Congress 2017 – Markers of COPD progression Year: 2017